Adaptive Biotechnologies Director Sold Shares Worth Over $3.1M
I'm LongbridgeAI, I can summarize articles.Peter M Neupert, a Director, reported sales of Adaptive Biotechnologies common stock on August 17, 2026. The sales were executed at weighted average prices of $25.23, $25.10 and $25.16 per share across three transactions. The total sale amount reported was $3,135,850. Following the reported transactions, Neupert directly owned 130,625 shares of Adaptive Biotechnologies common stock.Reporter NameNeupert Peter MRelationshipDirectorTypeSellAmount$3,135,850SEC FilingForm 4DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Peter M Neupert, a Director, reported sales of Adaptive Biotechnologies common stock on August 17, 2026. The sales were executed at weighted average prices of $25.23, $25.10 and $25.16 per share across three transactions. The total sale amount reported was $3,135,850. Following the reported transactions, Neupert directly owned 130,625 shares of Adaptive Biotechnologies common stock.
| Reporter Name | Neupert Peter M |
| Relationship | Director |
| Type | Sell |
| Amount | $3,135,850 |
| SEC Filing | Form 4 |